- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06621901
Effect of Protein on Endoplasmic Reticulum Stress
Effect of High Protein Diet on Endoplasmic Reticulum Stress
Study Overview
Status
Intervention / Treatment
Detailed Description
Today, many people are trying various nutritional models/diets to reduce body weight. One of the most popular of these diets is the diets that reduce carbohydrate intake. Western societies generally avoid high carbohydrate and fat intake. For this reason, interest in high protein intake in diets is increasing day by day. Although there is no general consensus on what a high protein diet (HPD) is, HPD applied for weight loss is a diet that contains approximately 30% of the energy provided by protein. The World Health Organization (WHO) has defined obesity as an endemic public problem and stated that its prevalence is increasing. With the increase in obesity, individuals are trying various dietary changes to achieve weight loss. These include diets with more regular macro and micronutrient patterns such as the Mediterranean Diet and DASH diet, and diets that may cause deficiencies in terms of macro and micronutrients such as Atkins, South Beach, Zone and Stillman, which contain high protein. The most important reasons for the interest in HPD are that it causes rapid weight loss and provides a feeling of satiety. This positive effect of HPDs on weight loss has attracted the attention of dietitians and has led them to increase the protein ratio in diets.
It is known that HPDs provide more effective results in body weight loss compared to low-protein diets. It is suggested that this effect occurs as a result of increased thermogenesis, increased satiety and suppressed appetite, and decreased glycemic index and glycemic load due to the replacement of refined carbohydrates with proteins. In addition to this positive effect on weight loss, HPD nutrition also has possible short- and long-term side effects. Known complications of long-term HPD nutrition include increased risk of cardiovascular disease, blood pressure, blood lipids, and renal dysfunction. Cardiovascular problems in particular are a source of concern, as they will eliminate the short-term positive effect of HPD on weight loss and increase the burden of cardiovascular disease in the long term. Studies generally focus on HPD and weight loss; there is limited data on the relationship between HPD nutrition and metabolic dysfunction such as endothelial dysfunction, inflammatory markers, antioxidant status, and other chronic diseases. The physiological, biochemical and molecular events that occur due to high protein diets are not fully understood and their results have not been explained.
High protein diets (especially low carbohydrate diets) are thought to have negative effects because they cause a decrease in fruit and vegetable consumption. In those who eat HPD, especially those with insufficient vitamins A, C and E in their diets, this will have a negative effect on antioxidant systems and will lead to the development of many chronic and metabolic diseases in the long term. Despite the positive effects of HPD applied as a weight loss diet in the short term, it is thought that the oxidative stress and inflammation it will create in the long term will cause an increase in chronic and metabolic diseases and comorbidities. This increase in the disease burden will increase health expenditures both individually and socially.
Increasing evidence has shown that ROS and inflammation increase the production of reactive oxygen species (ROS). There is a direct link between ROS production and cellular events such as protein oxidation and protein folding. ROS and ROS production are integral components of ERS and are not merely consequences of ERS induction. It has been reported that increased ERS triggers ERS and can cause various types of cell death. First, some forms of ROS can disrupt ER protein folding and trigger ERS. Exogenous oxidants such as ROS producers, peroxides, metal ions, and lipid oxidation products can activate some aspects of the UPR. 7-ketocholesterol, a major oxidation product of cholesterol in atherosclerotic plaque, induces the UPR in macrophages and vascular smooth muscle cells. The 7-ketocholesterol-activated UPR is suppressed by the antioxidant N-acetylcysteine, indicating that ERS induction is dependent on ERS. However, other forms of ROS such as hydrophene peroxide (H2O2) can only stimulate mild or specific components of the UPR. A study has determined that selenocysteine-free phospholipid hydroperoxide GPx (NPGPx), a member of the glutathione peroxidase (GPx) family, senses OS in the ER lumen and then forms a disulfide bond with GRP78, resulting in chaperone activity. Furthermore, OS induced during protein misfolding in the ER has led eukaryotic cells to develop antioxidative stress responses to restore cellular redox homeostasis. The PERK branch of the UPR induces two transcription factors, ATF4 and Nrf2, that transactivate antioxidative stress response genes, including SODs, HO-1, glutathione transferase, and uncoupler mitochondrial protein 2. The PERK signaling pathway of the UPR acts to maintain redox balance during ERS through activation of ATF4 and Nrf2. Small molecular antioxidants such as butylated hydroxyanisole (BHA) can prevent ERS-induced apoptosis and promote proper protein folding and secretion, suggesting a critical role for ERS in protein misfolding. As another example, two mitochondrial-targeted antioxidants, Mitoquinone and MitoTempol, have been shown to reduce mitochondrial ERS, ERS, and cell death in β cells. Antioxidants can suppress both ERS and ERS. Therefore, treatments targeting both stressors may be effective in preventing both ERS and metabolic, neurodegenerative, immune, and neoplastic diseases.
Therefore, the aim of this planned study is to examine the effect of HPD, which has gained popularity especially with its increasing use in weight loss diets, on ERS. Thus, scientific literature will be produced that can prevent the possible negative effects of HPD and at the same time, it can support the reduction of ERS, which is effective in the course of various chronic diseases.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Kayseri, Turkey (Türkiye)
- Erciyes University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Being between 19-45 years of age,
- Not changing physical activity throughout the study,
- Having a BMI of 18.5-24.9 kg/m2,
- Being healthy
Exclusion Criteria:
- Having a BMI of <18.5 and ≥25 kg/m2,
- Having a chronic disease,
- Smoking and drinking alcohol,
- Using vitamin-mineral supplements and herbal supplements,
- Being pregnant or breastfeeding,
- Having entered menopause,
- Being on any diet.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Fixed-Sequence Dietary Intervention
All participants received the same fixed sequence of dietary interventions.
Participants first received a high-protein diet for 10 days (40% carbohydrate, 30% protein, and 30% fat), followed by a two-week wash-out period during which they maintained their habitual dietary intake.
They subsequently received a normal-protein diet for 10 days (55% carbohydrate, 15% protein, and 30% fat).
Participants were instructed not to consume foods or beverages other than those permitted by the study protocol during both intervention periods.
The intervention order was not randomized.
|
Individuals will be placed on a high protein diet for 10 days.
Individuals will be placed on a normal protein diet for 10 days.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Endoplasmic reticulum stress after high protein diet
Time Frame: Day after diet end
|
After the diet, endoplasmic reticulum stress parameters (GRP78, PERK, Nrf2 and GPx-1) will be measured in the blood.
|
Day after diet end
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- ERU-BD-AOC-03
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Effect of High Protein Diet on Endoplasmic Reticulum Stress
-
James LewisNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Completed
-
Arkansas Children's Hospital Research InstituteCompletedEffect of Diet on Breast Milk CompositionUnited States
-
Badr UniversityCompletedEffect of High Intensity Laser Plus Exercises on Wrist PainEgypt
-
Chung Shan Medical UniversityCompletedPharmacokinetic Effect of AstraGin on Whey Protein Absorption and Muscle Function in Healthy SubjectsTaiwan
-
Cukurova UniversityActive, not recruitingEffect of Guided Imagery Application on Pregnancy Stress and Sleep Quality in Risky Pregnant Women Will Be CheckedTurkey
-
Milton S. Hershey Medical CenterCompletedEffect of Selenium on Oxidative Stress in Healthy MenUnited States
-
Harran UniversitySanliurfa Harran UniversityNot yet recruitingExamine the Effect of Stress Ball Use During the Intrapartum Period on Labor Pain and Childbirth Experience in Primiparous Women
Clinical Trials on High Protein Diet
-
Wageningen UniversityTop Institute Food and NutritionCompletedIdentify New Biomarkers in Blood or Urine After Consumption of Meat Protein, Dairy Protein and Grain Protein in Healthy Subjects.Netherlands
-
Rio de Janeiro State UniversityRio de Janeiro State Research Supporting Foundation (FAPERJ)Completed
-
Erik Ramirez LopezCompletedWeight Loss | Body CompositionMexico
-
University of BonnFederal Ministry of Food and Agriculture (BMEL); Federal Office for Agriculture...CompletedCardiovascular Diseases | Metabolic SyndromeGermany
-
Regional Hospital HolstebroCompleted
-
University of TennesseeUnknownInflammation | ObesityUnited States
-
University of KielCompleted
-
Federal University of UberlandiaCompletedShift Work Type Circadian Rhythm Sleep DisorderBrazil
-
Chang Gung Memorial HospitalCompletedIschemic Stroke | Diet, Healthy | Muscle LossTaiwan
-
Institute of Liver and Biliary Sciences, IndiaNot yet recruitingMetabolic Dysfunction Associated Fatty Liver DiseaseIndia